Product Information
CLONAZEPAM 0.125 MG ODT is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5240 per EA under NDC 62332036406. Its NADAC has been published 354 times since Nov 13, 2019.
FDA first approved this application on Jun 28, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.125 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332036406
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA211033FDA Approved
6/28/2019
TE Code
AB
On Market Since
7/1/2019
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.125 MG ODT has been published 354 times since Nov 13, 2019, and over the history we have for it it has declined 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5240 per EA |
|---|---|
| All-time high | $0.7914 (Jan 10, 2024) |
| All-time low | $0.4221 (Jul 17, 2024) |
| 52-week high | $0.6134 |
| 52-week low | $0.5038 |
| Median price | $0.5923 |
| Average price | $0.5960 |
| Largest weekly change | +47.8% (Aug 21, 2024) |
| Weeks tracked | 354 |
| Tracking since | Nov 13, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLONAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.125 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.125 MG ODT, manufactured by Alembic Pharmaceuticals Inc., is $0.5240 per EA (NDC 62332036406), effective Aug 19, 2026.
How has the price of CLONAZEPAM 0.125 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.125 MG ODT has declined 3.7%. It has been tracked across 354 weekly CMS publications since Nov 13, 2019.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.125 MG ODT?
Since Nov 13, 2019, the NADAC for CLONAZEPAM 0.125 MG ODT has ranged from a low of $0.4221 (Jul 17, 2024) to a high of $0.7914 (Jan 10, 2024), with a median of $0.5923 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.125 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of CLONAZEPAM 0.125 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLONAZEPAM 0.125 MG ODT?
CLONAZEPAM 0.125 MG ODT (NDC 62332036406) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.